2022
DOI: 10.1007/s10633-022-09915-6
|View full text |Cite
|
Sign up to set email alerts
|

Bardet–Biedl syndrome associated with novel compound heterozygous variants in BBS12 gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…In one of the families, in which five patients were affected, variability was observed not only in the overall clinical phenotype but also in the type of renal disease ( 16 ). Furthermore, after reviewing the literature, it was observed that a mutation in the BBS12 gene can be presented with a different constellation of symptoms characteristic of BBS ( 17 19 ). According to the available literature, patients with this mutation can have higher cardiovascular risks than those with mutation in BBS1 gene, since patients with mutations in BBS1 gene show low frequency of renal anomalies (potential cause of arterial hypertension) and generally present with milder phenotype while patients with mutations in BBS12 often present with obesity (associated with hyperlipidemia and glucose intolerance) ( 3 , 5 ).…”
Section: Discussionmentioning
confidence: 99%
“…In one of the families, in which five patients were affected, variability was observed not only in the overall clinical phenotype but also in the type of renal disease ( 16 ). Furthermore, after reviewing the literature, it was observed that a mutation in the BBS12 gene can be presented with a different constellation of symptoms characteristic of BBS ( 17 19 ). According to the available literature, patients with this mutation can have higher cardiovascular risks than those with mutation in BBS1 gene, since patients with mutations in BBS1 gene show low frequency of renal anomalies (potential cause of arterial hypertension) and generally present with milder phenotype while patients with mutations in BBS12 often present with obesity (associated with hyperlipidemia and glucose intolerance) ( 3 , 5 ).…”
Section: Discussionmentioning
confidence: 99%